BRIEF-EMA Starts Evaluating Use Of Kineret In COVID-19 Patients At Increased Risk Of Severe Respiratory Failure

* EMA STARTS EVALUATING USE OF KINERET IN ADULT COVID-19 PATIENTS AT INCREASED RISK OF SEVERE RESPIRATORY FAILURE

* EMA SAYS WILL COMMUNICATE ON OUTCOME OF ITS EVALUATION, WHICH IS EXPECTED BY OCTOBER UNLESS SUPPLEMENTARY INFORMATION IS NEEDED * EMA ON KINERET SAYS CHMP WILL ASSESS DATA SUBMITTED IN APPLICATION TO DECIDE WHETHER TO RECOMMEND EXTENSION OF INDICATION

Also Read: EU delivers enough doses to vaccinate 70% of adults, von der Leyen says